Abstract
There are many heart valve replacements currently available on the market; however, these devices are not ideal for pediatric patients with congenital heart valve defects. Decellularized valve substitutes offer potential for improved clinical outcomes and require pre-clinical testing guidelines and testing systems suitable for non-crosslinked, biological heart valves. The objective of this study was to assess the hydrodynamic performance of intact, bioengineered pulmonary valves using a custom pulse duplicator capable of testing intact biological valved conduits. The mechanical behavior of valve associated sinus and arterial tissue was also evaluated under biaxial loading. Cryopreserved, decellularized, extracellular matrix (ECM) conditioned and glutaraldehyde fixed valves showed reduced pressure gradients and increased effective orifice area for decellularized and ECM conditioned valves. ECM conditioning resulted in increased elastic modulus but decreased stretch in circumferential and longitudinal directions under biaxial loading. Overall, decellularization and ECM conditioning did not compromise the scaffolds, which exhibited satisfactory bench top performance.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13239-016-0275-9/MediaObjects/13239_2016_275_Fig1_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13239-016-0275-9/MediaObjects/13239_2016_275_Fig2_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13239-016-0275-9/MediaObjects/13239_2016_275_Fig3_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13239-016-0275-9/MediaObjects/13239_2016_275_Fig4_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13239-016-0275-9/MediaObjects/13239_2016_275_Fig5_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13239-016-0275-9/MediaObjects/13239_2016_275_Fig6_HTML.jpg)
Similar content being viewed by others
References
Baskett, R. J., M. A. Nanton, A. E. Warren, and D. B. Ross. Human leukocyte antigen-DR and ABO mismatch are associated with accelerated homograft valve failure in children: implications for therapeutic interventions. J. Thorac. Cardiovasc. Surg. 126(1):232–239, 2003; ((discussion 81)).
Bechtel, J. F., A. Marquardt, M. Muller-Steinhardt, T. Hankel, U. Stierle, and H. H. Sievers. Anti-HLA antibodies and pulmonary valve allograft function after the Ross procedure. J. Heart Valve Dis. 18(6):673–680, 2009.
Boer, U., A. Lohrenz, M. Klingenberg, A. Pich, A. Haverich, and M. Wilhelmi. The effect of detergent-based decellularization procedures on cellular proteins and immunogenicity in equine carotid artery grafts. Biomaterials. 32(36):9730–9737, 2011. doi:10.1016/j.biomaterials.2011.09.015.
Boethig, D., H. Goerler, M. Westhoff-Bleck, M. Ono, A. Daiber, A. Haverich, et al. Evaluation of 188 consecutive homografts implanted in pulmonary position after 20 years. Eur. J. Cardio-thorac. Surg 32(1):133–142, 2007. doi:10.1016/j.ejcts.2007.02.025.
Bottio, T., V. Tarzia, C. Dal Lin, E. Buratto, G. Rizzoli, M. Spina, et al. The changing hydrodynamic performance of the decellularized intact porcine aortic root: considerations on in vitro testing. J. Heart Valve Dis. 19(4):485–491, 2010.
Converse, G. L., M. Armstrong, R. W. Quinn, E. E. Buse, M. L. Cromwell, S. J. Moriarty, et al. Effects of cryopreservation, decellularization and novel extracellular matrix conditioning on the quasi-static and time-dependent properties of the pulmonary valve leaflet. Acta Biomater. 8(7):2722–2729, 2012. doi:10.1016/j.actbio.2012.03.047.
Converse, G. L., E. E. Buse, K. R. Neill, C. R. McFall, H. N. Lewis, M. C. VeDepo, et al. Design and efficacy of a single-use bioreactor for heart valve tissue engineering. J. Biomed. Mater. Res. B Appl. Biomater. 2015. doi:10.1002/jbm.b.33552.
Gilbert, T. W., T. L. Sellaro, and S. F. Badylak. Decellularization of tissues and organs. Biomaterials 27(19):3675–3683, 2006. doi:10.1016/j.biomaterials.2006.02.014.
Hooper, D. K., J. A. Hawkins, T. C. Fuller, T. Profaizer, and R. E. Shaddy. Panel-reactive antibodies late after allograft implantation in children. Ann. Thorac. Surg. 79(2):641–644, 2005. doi:10.1016/j.athoracsur.2004.07.052; ((discussion 5)).
Hopkins, R. A., A. L. Jones, L. Wolfinbarger, M. A. Moore, A. A. Bert, G. K. Lofland. Decellularization reduces calcification while improving both durability and 1-year functional results of pulmonary homograft valves in juvenile sheep. J. Thorac. Cardiovasc. Surg. 137(4):907–913, 13e1-4, 2009. doi:10.1016/j.jtcvs.2008.12.009.
Standardization IOo. Cardiovascular implants—cardiac valve prostheses—Part 2: surgically implanted heart valve substitues. ISO 5840-2:20142014.
Standardization IOo. Cardiovascular implants—cardiac valve prostheses—Part 3: heart valve substitutes implanted by transcatheter techniques. ISO 5840-3:20132013.
Karamlou, T., E. H. Blackstone, J. A. Hawkins, M. L. Jacobs, K. R. Kanter, J. W. Brown, et al. Can pulmonary conduit dysfunction and failure be reduced in infants and children less than age 2 years at initial implantation? J. Thorac. Cardiovasc. Surg. 132(4):829–838, 2006. doi:10.1016/j.jtcvs.2006.06.034.
Kaza, A. K., H. G. Lim, D. J. Dibardino, V. Bautista-Hernandez, J. Robinson, C. Allan, et al. Long-term results of right ventricular outflow tract reconstruction in neonatal cardiac surgery: options and outcomes. J. Thorac. Cardiovasc. Surg. 138(4):911–916, 2009. doi:10.1016/j.jtcvs.2008.10.058.
Lee, C., C. S. Park, C. H. Lee, J. G. Kwak, S. J. Kim, W. S. Shim, et al. Durability of bioprosthetic valves in the pulmonary position: long-term follow-up of 181 implants in patients with congenital heart disease. J. Thorac. Cardiovasc. Surg. 142(2):351–358, 2011. doi:10.1016/j.jtcvs.2010.12.020.
Lehr, E. J., G. R. Rayat, B. Chiu, T. Churchill, L. E. McGann, J. Y. Coe, et al. Decellularization reduces immunogenicity of sheep pulmonary artery vascular patches. J. Thorac. Cardiovasc. Surg. 141(4):1056–1062, 2011. doi:10.1016/j.jtcvs.2010.02.060.
Liao, J., E. M. Joyce, and M. S. Sacks. Effects of decellularization on the mechanical and structural properties of the porcine aortic valve leaflet. Biomaterials 29(8):1065–1074, 2008. doi:10.1016/j.biomaterials.2007.11.007.
Mendoza-Novelo, B., E. E. Avila, J. V. Cauich-Rodriguez, E. Jorge-Herrero, F. J. Rojo, G. V. Guinea, et al. Decellularization of pericardial tissue and its impact on tensile viscoelasticity and glycosaminoglycan content. Acta Biomater. 7(3):1241–1248, 2011. doi:10.1016/j.actbio.2010.11.017.
Poynter, J. A., P. Eghtesady, B. W. McCrindle, H. L. Walters, 3rd, P. M. Kirshbom, E. H. Blackstone, et al. Association of pulmonary conduit type and size with durability in infants and young children. Ann. Thorac. Surg. 96(5):1695–1701, 2013. doi:10.1016/j.athoracsur.2013.05.074; ((discussion 701–702)).
Quinn, R. W., S. L. Hilbert, A. A. Bert, B. W. Drake, J. A. Bustamante, J. E. Fenton, et al. Performance and morphology of decellularized pulmonary valves implanted in juvenile sheep. Ann. Thorac Surg. 92(1):131–137, 2011. doi:10.1016/j.athoracsur.2011.03.039.
Quinn, R. W., S. L. Hilbert, G. L. Converse, A. A. Bert, E. Buse, W. B. Drake, et al. Enhanced autologous re-endothelialization of decellularized and extracellular matrix conditioned allografts implanted into the right ventricular outflow tracts of juvenile sheep. Cardiovascular engineering and technology. 3(2):217–227, 2012. doi:10.1007/s13239-011-0078-y.
Sanders, B., S. Loerakker, E. S. Fioretta, D. J. Bax, A. Driessen-Mol, S. P. Hoerstrup, et al. Improved geometry of decellularized tissue engineered heart valves to prevent leaflet retraction. Ann. Biomed. Eng. 44(4):1061–1071, 2016. doi:10.1007/s10439-015-1386-4.
Schmidt, D., P. E. Dijkman, A. Driessen-Mol, R. Stenger, C. Mariani, A. Puolakka, et al. Minimally-invasive implantation of living tissue engineered heart valves: a comprehensive approach from autologous vascular cells to stem cells. J. Am. Coll Cardiol. 56(6):510–520, 2010. doi:10.1016/j.jacc.2010.04.024.
Sedaghat, A., J. M. Sinning, M. Utzenrath, P. F. Ghalati, C. Schmitz, N. Werner, et al. Hydrodynamic performance of the medtronic corevalve and the edwards SAPIEN XT transcatheter heart valve in surgical bioprostheses: an in vitro valve-in-valve model. Ann Thorac Surg. 101(1):118–124, 2016. doi:10.1016/j.athoracsur.2015.06.047.
Seebacher, G., C. Grasl, M. Stoiber, E. Rieder, M. T. Kasimir, D. Dunkler, et al. Biomechanical properties of decellularized porcine pulmonary valve conduits. Artif Organs. 32(1):28–35, 2008. doi:10.1111/j.1525-1594.2007.00452.x.
Sheridan, W. S., G. P. Duffy, and B. P. Murphy. Mechanical characterization of a customized decellularized scaffold for vascular tissue engineering. J. Mech. Behav. Biomed. Mater. 8:58–70, 2012. doi:10.1016/j.jmbbm.2011.12.003.
Tudorache, I., S. Cebotari, G. Sturz, L. Kirsch, C. Hurschler, A. Hilfiker, et al. Tissue engineering of heart valves: biomechanical and morphological properties of decellularized heart valves. J. Heart Valve Dis. 16(5):567–573, 2007; ((discussion 74)).
US Food and Drug Administration CfDaRH. Draft guidance for industry and FDA staff: heart valves—in vestigational device exemption (IDE) and premarket approval (PMA) applications, 2010.
Weymann, A., T. Radovits, B. Schmack, S. Korkmaz, S. Li, N. Chaimow, et al. Total aortic arch replacement: superior ventriculo-arterial coupling with decellularized allografts compared with conventional prostheses. PloS One 9(7):e103588, 2014. doi:10.1371/journal.pone.0103588.
Williams, C., J. Liao, E. M. Joyce, B. Wang, J. B. Leach, M. S. Sacks, et al. Altered structural and mechanical properties in decellularized rabbit carotid arteries. Acta Biomater. 5(4):993–1005, 2009. doi:10.1016/j.actbio.2008.11.028.
Yoganathan, A. P., M. Fogel, S. Gamble, M. Morton, P. Schmidt, J. Secunda, et al. A new paradigm for obtaining marketing approval for pediatric-sized prosthetic heart valves. J. Thorac. Cardiovasc. Surg. 146(4):879–886, 2013. doi:10.1016/j.jtcvs.2013.04.016.
Zou, Y., and Y. Zhang. Mechanical evaluation of decellularized porcine thoracic aorta. J. Surg. Res. 175(2):359–368, 2012. doi:10.1016/j.jss.2011.03.070.
Acknowledgments
This work was partially funded through generous grant support from the Katherine B. Richardson Foundation at Children’s Mercy.
Conflict of Interest
Authors Buse, Hopkins and Converse are listed inventors on pending patent 14/390,170. Author Hopkins is a listed inventor on the following patents: 10/0035344 A1; 12/813,487; 2010/0042120 A1; 6,652583 B2; 2009257400; 20130280319 A1. Author Hopkins reports grants from LifeNet Health, outside of the submitted work. Author Hilbert declares that he has no conflict of interest.
Statement of Human Studies
No human studies were carried out by the authors for this article.
Statement of Animal Studies
All institutional and national guidelines for the care and use of laboratory animals were followed and approved by the appropriate institutional committees.
Author information
Authors and Affiliations
Corresponding author
Additional information
Associate Editor Ajit P. Yoganathan oversaw the review of this article.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Buse, E.E., Hilbert, S.L., Hopkins, R.A. et al. Pulse Duplicator Hydrodynamic Testing of Bioengineered Biological Heart Valves. Cardiovasc Eng Tech 7, 352–362 (2016). https://doi.org/10.1007/s13239-016-0275-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13239-016-0275-9